Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Small cell lung cancer metabolome (part II)

ABSTRACT:

ORGANISM(S): Homo Sapiens

TISSUE(S): Lung

DISEASE(S): Cancer

PROVIDER: ST000220 | MetabolomicsWorkbench |

REPOSITORIES: MetabolomicsWorkbench

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	mwtab	Other

Items per page:

1 - 1 of 1

Similar Datasets

In-depth proteomic analyses reveal unique subtype-specific signatures in small cell lung cancer (part II: cell media)

Project description:Small-cell lung cancer (SCLC) represents about 13–15% of all lung cancers and with a five-year survival rate of less than 7%, it remains one of the most lethal forms of malignant diseases. It has a very aggressive course and is characterized by extensive chromosomal rearrangements, high mutation burden, and almost universal inactivation of the tumor suppressor genes TP53 and RB1. Therefore, the vast majority of SCLC patients are diagnosed with extensive-stage disease when surgery is not feasible and the treatment options are mostly limited to cytotoxic chemotherapy (CHT) and radiation. Importantly, targeted therapies for these patients have so far failed, and the success of immunotherapy in non-SCLC (NSCLC) has not been reflected in SCLC. Although SCLC has been formerly considered as a homogeneous disease with a single morphological type, recent advances in SCLC research have led to the development of subtype-specific classifications primarily based on neuroendocrine (NE) features and unique molecular profiles. Here, we investigate the general cell line characteristics on protein level, the relationship between the RNA-based classification and the protein expression profile, and the distinct biological processes specific for each subtype.

2022-10-14 | PXD029821 | Pride

RNA sequencing analysis of NGFR ablation in both p53-positive and negative non-small-cell lung cancer cell lines

Project description:We report the gene expression profiles by NGFR knockdown in H460 and H1299 cell lines and reveal that NGFR ablation activates p53 target gene expression. We examined gene expression in two different non-small-cell lung cancer cell lines, one with wild-type p53 and the other without p53.

2016-06-10 | E-GEOD-79051 | biostudies-arrayexpress

Propofol mediates non-small cell lung cancer growth in part by regulating circ_0003028-related mechanisms.

Project description: Not available

| S-EPMC10260504 | biostudies-literature

Non-small cell lung cancer global proteomics

Project description:We present data of global proteomes for non-small cell lung cancer for squamous cell and adenocarcinoma, and for normal adjacent tissue.

2024-12-17 | PXD054390 | Pride

Elevated expression of annexin II (lipocortin II, p36) in a multidrug resistant small cell lung cancer cell line.

Project description: Not available

| S-EPMC1977565 | biostudies-other

Small-cell lung cancer.

Project description: Not available

| S-EPMC8177722 | biostudies-literature